Complications of Acute Pancreatitis Misdiagnosed as Primary Serous Papillary Carcinoma

Abstract

Purpose: The goal of this study was to determine the clinical and therapeutic characteristics of women with a primary peritoneal carcinoma (PPC). Results:The median overall survival of all patients was 23.1 months. The estimated 3-year survival rate was 29% (SE, 13% ). The response rate to first-line platinum-based chemotherapy was 79% and the median time to treatment failure was 9.9 months (95% confidence interval, 1.38～ 18.4 months). By univariate and multivariate analysis, performance status was the only significant factor associated with overall survival (p＜0.05).Conclusion: W e evaluated the clinical characteristics and treatment response of patients with a primary peritoneal carcinoma. Our results showed that it is possible to achieve long-term survival in patients with PPC. A further clinical study is to need to establish clinical characteristics and treatment outcomes.